Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers: Questions and Answers Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 10, 2017
April 22, 2020
96ea5b7a-1312-43e3-91d9-d9e770a90ee6
Related Documents
Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs — General Considerations
Guidance DocumentMarch 18, 2014Center for Drug Evaluation and Research
DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers
Guidance DocumentDecember 9, 2014Center for Drug Evaluation and Research
Identifying Trading Partners Under the Drug Supply Chain Security Act
Guidance DocumentJuly 5, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.